Basic Information
| RNALocate ID: | RLID:11002957 |
| RNA Symbol: | hsa-miR-491-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-491-5p |
| RNA ID: | miRBase:MIMAT0002807 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002320 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002321 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002322 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002955 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11002956 | Extracellular Vesicle | Plasma | 28588009 |
| RLID-D:11000476 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001243 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-491-5p | Medulloblastoma | MNDR-E-MI-54235 |
| MNDR | hsa-miR-491-5p | Neurofibromatosis 1 | MNDR-E-MI-54236 |
| MNDR | hsa-miR-491-5p | Dermatomyositis | MNDR-E-MI-54237 |
| MNDR | hsa-miR-491-5p | Prostate cancer | MNDR-E-MI-54238 |
| MNDR | hsa-miR-491-5p | Gastric cancer | MNDR-E-MI-54239 |
| MNDR | hsa-miR-491-5p | Alzheimer disease | MNDR-E-MI-54240 |
| MNDR | hsa-miR-491-5p | Esophageal carcinoma | MNDR-E-MI-54241 |
| MNDR | hsa-miR-491-5p | Dysautonomia familial | MNDR-E-MI-54242 |
| MNDR | hsa-miR-491-5p | Head and neck cancer | MNDR-E-MI-54243 |
| MNDR | hsa-miR-491-5p | Lung cancer | MNDR-E-MI-54244 |
| MNDR | hsa-miR-491-5p | Parkinson disease | MNDR-E-MI-54245 |
| MNDR | hsa-miR-491-5p | Pituitary neoplasms | MNDR-E-MI-54246 |
| MNDR | hsa-miR-491-5p | Pancreatic cancer | MNDR-E-MI-54247 |
| MNDR | hsa-miR-491-5p | Melanoma | MNDR-E-MI-54248 |
| MNDR | hsa-miR-491-5p | Rectum adenocarcinoma | MNDR-E-MI-54249 |
| MNDR | hsa-miR-491-5p | Colon cancer | MNDR-E-MI-54250 |
| MNDR | hsa-miR-491-5p | Ischemic attack transient | MNDR-E-MI-54251 |
| MNDR | hsa-miR-491-5p | Colon adenocarcinoma | MNDR-E-MI-54252 |
| MNDR | hsa-miR-491-5p | Multiple sclerosis | MNDR-E-MI-54253 |
| MNDR | hsa-miR-491-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-54254 |
| MNDR | hsa-miR-491-5p | Familial ovarian cancer | MNDR-E-MI-54255 |
| MNDR | hsa-miR-491-5p | Prostate adenocarcinoma | MNDR-E-MI-54256 |
| MNDR | hsa-miR-491-5p | Carcinoma ductal breast | MNDR-E-MI-54257 |
| MNDR | hsa-miR-491-5p | Glioblastoma | MNDR-E-MI-54258 |
| MNDR | hsa-miR-491-5p | Glioma | MNDR-E-MI-54259 |
| MNDR | hsa-miR-491-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-54260 |
| MNDR | hsa-miR-491-5p | Osteosarcoma | MNDR-E-MI-54261 |
| MNDR | hsa-miR-491-5p | Inclusion body myositis | MNDR-E-MI-54262 |
| MNDR | hsa-miR-491-5p | Liver cancer | MNDR-E-MI-54263 |
| MNDR | hsa-miR-491-5p | Gastric adenocarcinoma | MNDR-E-MI-54264 |
| MNDR | hsa-miR-491-5p | Pituitary adenoma | MNDR-E-MI-54265 |
| MNDR | hsa-miR-491-5p | Lung squamous cell carcinoma | MNDR-E-MI-54266 |
| MNDR | hsa-miR-491-5p | Carcinoma lung non-small-cell | MNDR-E-MI-54267 |
| MNDR | hsa-miR-491-5p | Lung adenocarcinoma | MNDR-E-MI-54268 |
| MNDR | hsa-miR-491-5p | Cervical cancer | MNDR-E-MI-54269 |
| MNDR | hsa-miR-491-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54270 |
| MNDR | hsa-miR-491-5p | Cholangiocarcinoma | MNDR-E-MI-54271 |
| MNDR | hsa-miR-491-5p | Prolactinoma | MNDR-E-MI-54272 |
| MNDR | hsa-miR-491-5p | Lung small cell carcinoma | MNDR-E-MI-54273 |
| MNDR | hsa-miR-491-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-54274 |
| MNDR | hsa-miR-491-5p | Adenoma | MNDR-E-MI-54275 |
| MNDR | hsa-miR-491-5p | Breast invasive carcinoma | MNDR-E-MI-54276 |
| MNDR | hsa-miR-491-5p | Hepatocellular carcinoma | MNDR-E-MI-54277 |
| MNDR | hsa-miR-491-5p | Familiar ovarian carcinoma | MNDR-E-MI-54278 |
| MNDR | hsa-miR-491-5p | Acute myelocytic leukemia | MNDR-E-MI-54279 |
| MNDR | hsa-miR-491-5p | Colorectal cancer | MNDR-E-MI-54280 |
| MNDR | hsa-miR-491-5p | Nasopharyngeal carcinoma | MNDR-E-MI-54281 |
| MNDR | hsa-miR-491-5p | Nasopharynx carcinoma | MNDR-E-MI-54282 |
| MNDR | hsa-miR-491-5p | Uterine cervical neoplasms | MNDR-E-MI-54283 |
| MNDR | hsa-miR-491-5p | Nasopharyngeal cancer | MNDR-E-MI-54284 |
| MNDR | hsa-miR-491-5p | Stroke lacunar | MNDR-E-MI-54285 |
| MNDR | hsa-miR-491-5p | HPV | MNDR-E-MI-54286 |
| MNDR | hsa-miR-491-5p | Multiple sclerosis susceptibility | MNDR-E-MI-54287 |
| MNDR | hsa-miR-491-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-54288 |
| MNDR | hsa-miR-491-5p | Tubulovillous adenoma | MNDR-E-MI-54289 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2L1 | Homo sapiens | RR00219219 |
TOP